Michael Martin Breen, Executive Chairman/Interim CEO: GT Biopharma GTBP Buy · Filed 23/04/11

Trade details

Type: Insider buy
Amount: $25,000
Shares · price: 50,000 sh · $0.50 a share
Held after: 656,218 sh
Stock: GT Biopharma GTBP
Person: Michael Martin BreenExecutive Chairman/Interim CEO
Trade date: 23/04/11
Filed: 23/04/11
Days to filing: 0 days

2 insiders bought this week

Insiders buying this week: 2 insiders
Holding change: +8.2%

GT Biopharma trades, last 26 weeks

What else happened in GT Biopharma around then

Filed or reported within 30 days of the trade day · 23/03/12~23/05/11

Michael Martin Breen's recent trades

Michael Martin BreenDirector
BuyPrairie Operating
Buy
Prairie Operating
PROP
$100.8K
916,112 sh
$100.8K
Filed 23/05/05
Traded 23/05/03